Form 10-Q Bausch Health Companies For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Bausch Health Companies (BHC) PT Lowered to $10 at RBC Capital
May 3, 2024 6:36 AM EDTRBC Capital analyst Doug Miehm lowered the price target on Bausch Health Companies (NYSE: BHC) to $10.00 (from $11.00) while maintaining a Sector Perform rating.
The analyst comments "Between Q1 EBITDA that was weaker than expected and little incremental visibility on the BLCO separation... More
